Finance

Lists
PNTG:NASDAQ
Pennant Group Inc
$36.37
+0.30%
(+0.11) 1D
Nov 10, 2:23:08 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PNTG...
Open
$36.27
High
$36.70
Low
$35.28
Mkt. cap
1.28B
Avg. vol.
399.82K
Volume
307.33K
P/E ratio
36.39
52-wk high
$44.24
52-wk low
$24.21
EPS
$1.00
Beta
1.33
Shares outstanding
35.13M
No. of employees
10K
Open
$36.27
High
$36.70
Low
$35.28
Mkt. cap
1.28B
Avg. vol.
399.82K
Volume
307.33K
P/E ratio
36.39
52-wk high
$44.24
52-wk low
$24.21
EPS
$1.00
Beta
1.33
Shares outstanding
35.13M
No. of employees
10K
News stories
From web sources and news partners
About Pennant Group Inc
CEO-
Employees9.7K
Founded2019
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitepennantgroup.com
Analyst ratings
Based on 3 analysts giving stock ratings to PNTG in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PNTG in the last 3 months.
Highest
Current $36.37
$50.00 (+37.48%)
Average
$48.67 (+33.82%)
Lowest
$48.00 (+31.98%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Buy
Reiterated
$48.00
+32%
11/06/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$48.00
+32%
11/05/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$50.00
+37.5%
11/05/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
$46.00
+26.5%
08/10/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Unknown Analyst
Stephens
Buy
Maintained
$37.00
+1.7%
04/02/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.35 / $0.35
-1.21%miss
Revenue / Est. (USD)
302.25M / 299.47M
+0.93%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
289.32M
285.36M
297.98M
302.25M
Cost of goods sold
226.82M
230.35M
241.38M
246.58M
Cost of revenue
226.82M
230.35M
241.38M
246.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.07M
35.50M
35.04M
34.43M
Operating expense
44.43M
38.12M
38.15M
38.11M
Total operating expenses
271.25M
268.47M
279.53M
284.69M
Operating income
18.07M
16.89M
18.45M
17.56M
Other non operating income
54.00K
-146.00K
626.00K
-78.00K
EBT including unusual items
14.27M
14.09M
14.83M
14.19M
EBT excluding unusual items
14.87M
13.68M
16.10M
15.24M
Income tax expense
3.90M
3.79M
3.94M
3.12M
Effective tax rate
27.30%
26.93%
26.53%
21.97%
Other operating expenses
-
-
-
-
Net income
8.64M
8.52M
9.08M
9.64M
Net profit margin
2.99%
2.99%
3.05%
3.19%
Earnings per share
0.34
0.32
0.36
0.35
Interest and investment income
-
-
-
-
Interest expense
-3.25M
-3.07M
-3.35M
-3.62M
Net interest expenses
-3.25M
-3.07M
-3.35M
-3.62M
Depreciation and amortization charges
2.36M
2.62M
3.11M
3.68M
EBITDA
20.43M
19.51M
21.56M
21.24M
Gain or loss from assets sale
100.00K
-
9.00K
-504.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps